Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] - N0000182639

Pharmacologic Code	N0000182639
Pharmacologic Name	Hepatitis C Virus NS3/4A Protease Inhibitor
Pharmacologic Uses	hepatitis C virus (HCV) NS3/4A protease inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Hepatitis C Virus NS3/4A Protease Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0006-3074	Zepatier	Non-Proprietary Name: Elbasvir And Grazoprevir	Tablet, Film Coated	Oral	Merck Sharp & Dohme Llc	ACTIVE
	0074-2600	Mavyret	Non-Proprietary Name: Glecaprevir And Pibrentasvir	Pellet	Oral	Abbvie Inc.	ACTIVE
	0074-2625	Mavyret	Non-Proprietary Name: Glecaprevir And Pibrentasvir	Tablet, Film Coated	Oral	Abbvie Inc.	ACTIVE
	61958-2401	Vosevi	Non-Proprietary Name: Sofosbuvir, Velpatasvir, And Voxilaprevir	Tablet, Film Coated	Oral	Gilead Sciences, Inc.	ACTIVE